- Home
- DLB
as 07-26-2024 4:00pm EST
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
| Founded: | 1965 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 7.6B | IPO Year: | 2005 |
| Target Price: | $98.67 | AVG Volume (30 days): | 398.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.96 | EPS Growth: | -20.97 |
| 52 Week Low/High: | $75.87 - $90.06 | Next Earning Date: | 08-07-2024 |
| Revenue: | $1,269,029,000 | Revenue Growth: | -0.75% |
| Revenue Growth (this year): | 0.48% | Revenue Growth (next year): | 5.36% |
Stock Insider Trading Activity of Dolby Laboratories (DLB)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| SHERMAN MARK ANDREW | DLB | EVP, Gen. Counsel & Secretary | May 28 '24 | Sell | $79.62 | 2,283 | $181,772.46 | 58,325 | SEC Form 4 |
| Rollins Emily | DLB | Director | Mar 1 '24 | Sell | $80.88 | 1,000 | $80,880.00 | 7,493 | SEC Form 4 |
| Pendleton Todd | DLB | SVP, Chief Marketing Officer | Feb 28 '24 | Sell | $81.69 | 24,395 | $1,992,798.28 | 35,694 | SEC Form 4 |
| Couling John D | DLB | SVP, Entertainment | Feb 8 '24 | Sell | $80.00 | 50,000 | $4,000,000.00 | 108,519 | SEC Form 4 |
| Couling John D | DLB | SVP, Entertainment | Feb 8 '24 | Sell | $80.81 | 33,560 | $2,711,896.34 | 108,519 | SEC Form 4 |
| Couling John D | DLB | SVP, Entertainment | Feb 8 '24 | Sell | $80.00 | 50,000 | $4,000,000.00 | 108,519 | SEC Form 4 |
| Couling John D | DLB | SVP, Entertainment | Feb 8 '24 | Sell | $80.81 | 33,560 | $2,711,896.34 | 108,519 | SEC Form 4 |
| YEAMAN KEVIN J | DLB | President and CEO | Jan 17 '24 | Sell | $83.51 | 9,030 | $754,082.66 | 83,721 | SEC Form 4 |
| SHERMAN MARK ANDREW | DLB | EVP, Gen. Counsel & Secretary | Dec 15 '23 | Sell | $86.19 | 8,856 | $763,270.30 | 59,988 | SEC Form 4 |
| SHERMAN MARK ANDREW | DLB | EVP, Gen. Counsel & Secretary | Dec 15 '23 | Sell | $86.01 | 1,663 | $143,038.29 | 58,325 | SEC Form 4 |
| YEAMAN KEVIN J | DLB | President and CEO | Dec 12 '23 | Sell | $89.17 | 18,060 | $1,610,435.48 | 51,879 | SEC Form 4 |
| YEAMAN KEVIN J | DLB | President and CEO | Nov 21 '23 | Sell | $83.98 | 9,030 | $758,378.23 | 87,999 | SEC Form 4 |
| YEAMAN KEVIN J | DLB | President and CEO | Nov 21 '23 | Sell | $85.00 | 36,120 | $3,070,200.00 | 51,879 | SEC Form 4 |
Latest Dolby Laboratories News
DLB Breaking Stock News: Dive into DLB Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Is the Options Market Predicting a Spike in Dolby Laboratories (DLB) Stock?
Simply Wall St.
15 days ago
Does The Market Have A Low Tolerance For Dolby Laboratories, Inc.'s (NYSE:DLB) Mixed Fundamentals?
PR Newswire
18 days ago
Dolby Laboratories Announces Conference Call and Webcast for Q3 Fiscal 2024 Financial Results
The Telegraph
2 months ago
Italian energy company targets Britain for fleet of 20 mini-nukes
Motley Fool
2 months ago
4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
AFP
2 months ago
Seoul resumes loudspeaker propaganda against North
Simply Wall St.
2 months ago
Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss
Simply Wall St.
2 months ago
American Software Full Year 2024 Earnings: EPS Beats Expectations
Compare DLB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DLB Dolby Laboratories - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.